#lupus — Thursday, September 10, 2026 (1 items)
| 0 | ℹ |
A bispecific CD3xCD19 antibody for systemic lupus erythematosus: a phase 1 trial.
(nature.com)
|
Nature Medicine 2026-09-10 | #immunotherapy #autoimmunity #lupus #clinical trial #bispecific |